Treatment of Enterococcus faecalis with Colony Count of 10,000 to 49,000
Colony counts of Enterococcus faecalis between 10,000 to 49,000 generally do not require treatment unless associated with clinical symptoms or specific high-risk conditions. This approach is supported by current clinical guidelines that emphasize the importance of differentiating between colonization and true infection before initiating antimicrobial therapy 1.
Decision Algorithm for Treatment
When NOT to Treat:
- Asymptomatic patients
- Isolated finding without clinical correlation
- Colonization rather than true infection
- Low-risk patients without indwelling devices or immunocompromise
When to Consider Treatment:
Symptomatic infection
- Fever, pain, or other clinical signs specific to the site of infection
- Elevated inflammatory markers
High-risk patients
- Prosthetic heart valves or intravascular devices
- Immunocompromised status
- Recent surgery or invasive procedures
- History of endocarditis
Specific infection sites
- Central venous catheter-related infections
- Endocarditis
- Intra-abdominal infections with clinical significance
Treatment Options When Indicated
If treatment is deemed necessary based on clinical presentation:
First-line therapy:
- Ampicillin is the first-line treatment for E. faecalis infections 1
- Dosing: 2g IV every 4 hours
Alternative options:
Vancomycin for patients with penicillin allergy 1, 2
- Dosing: 30 mg/kg/day IV in 2 divided doses
- Target trough levels: 10-20 μg/mL
Linezolid for resistant strains 3
- Dosing: 600 mg IV/oral every 12 hours
Daptomycin for serious infections or when first-line options fail 1, 4
- Dosing: 8-12 mg/kg/day for serious enterococcal infections
Important Clinical Considerations
Intrinsic Resistance Patterns
- E. faecalis is intrinsically resistant to cephalosporins when used as monotherapy 1
- Using cephalosporins alone is a common mistake in treatment
Duration of Therapy
- Uncomplicated infections: 7-14 days
- Bloodstream infections with central venous catheters: 10-14 days 3, 1
- Endocarditis: 4-6 weeks depending on duration of symptoms 1
Catheter Management
- For catheter-related infections, catheter removal is generally recommended 3
- In cases of Enterococcus infection specifically, the catheter can sometimes be retained with systemic antibiotic therapy 3
Monitoring
- Weekly renal function tests with aminoglycoside therapy
- Weekly complete blood counts with linezolid therapy
- Weekly creatine kinase levels with daptomycin therapy 1
Special Situations
Endocarditis Risk
- E. faecalis has higher risk of endocarditis than E. faecium 3
- Consider transesophageal echocardiogram (TEE) if clinical signs of endocarditis are present 3
Multidrug-Resistant Strains
- For vancomycin-resistant enterococci (VRE), linezolid or tigecycline are appropriate options 3
- Combination therapies may be necessary for difficult-to-treat infections 5, 6
Remember that the presence of E. faecalis in clinical samples, particularly in healthcare-associated settings, can be associated with poor outcomes if true infection is present and left untreated 3. However, unnecessary antibiotic treatment contributes to antimicrobial resistance and should be avoided when the organism represents colonization rather than infection.